Roni Oren

1.7k total citations
28 papers, 1.0k citations indexed

About

Roni Oren is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Roni Oren has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Genetics. Recurrent topics in Roni Oren's work include Glioma Diagnosis and Treatment (4 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Roni Oren is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Roni Oren collaborates with scholars based in Israel, United States and Czechia. Roni Oren's co-authors include Michael Aviram, Mira Rosenblat, Leonid Gaidukov, Jacob Vaya, Tomer Nir, Eran Hornstein, Olga Khersonsky, Sharon Kredo‐Russo, Amitai D. Mandelbaum and Tal Melkman-Zehavi and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Roni Oren

26 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roni Oren Israel 15 427 268 213 191 181 28 1.0k
Fuxiang Zhou China 24 862 2.0× 345 1.3× 76 0.4× 223 1.2× 55 0.3× 78 1.2k
Chaoxin Hu United States 13 434 1.0× 128 0.5× 41 0.2× 367 1.9× 54 0.3× 18 920
Pamela Hale United States 13 500 1.2× 244 0.9× 98 0.5× 176 0.9× 17 0.1× 17 1.2k
Seishi Nagamori Japan 18 462 1.1× 117 0.4× 235 1.1× 207 1.1× 64 0.4× 50 1.1k
Junjeong Choi South Korea 17 746 1.7× 645 2.4× 95 0.4× 441 2.3× 19 0.1× 42 1.4k
Akimitsu Konishi Japan 16 1.0k 2.4× 198 0.7× 42 0.2× 314 1.6× 42 0.2× 23 1.5k
Yanping Gong China 21 517 1.2× 201 0.8× 266 1.2× 219 1.1× 26 0.1× 54 1.1k
Chang Xian Li China 17 451 1.1× 266 1.0× 191 0.9× 300 1.6× 11 0.1× 29 1.2k

Countries citing papers authored by Roni Oren

Since Specialization
Citations

This map shows the geographic impact of Roni Oren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roni Oren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roni Oren more than expected).

Fields of papers citing papers by Roni Oren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roni Oren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roni Oren. The network helps show where Roni Oren may publish in the future.

Co-authorship network of co-authors of Roni Oren

This figure shows the co-authorship network connecting the top 25 collaborators of Roni Oren. A scholar is included among the top collaborators of Roni Oren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roni Oren. Roni Oren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oren, Roni, Bareket Dassa, A.N. Plotnikov, et al.. (2024). Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas. eLife. 13. 3 indexed citations
2.
Oren, Roni, Bareket Dassa, A.N. Plotnikov, et al.. (2024). Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas. eLife. 13. 3 indexed citations
3.
Milenković, Ivan, Inbal Biton, Mirie Zerbib, et al.. (2024). Efficacy of an AAV vector encoding a thermostable form of glucocerebrosidase in alleviating symptoms in a Gaucher disease mouse model. Gene Therapy. 31(9-10). 439–444. 1 indexed citations
4.
Simoni‐Nieves, Arturo, Moshit Lindzen, Donatella Romaniello, et al.. (2024). A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib. Cell Reports Medicine. 5(9). 101703–101703. 9 indexed citations
5.
Prasad, Pragati K., Inna Goliand, Roni Oren, et al.. (2023). Chemically programmable bacterial probes for the recognition of cell surface proteins. Materials Today Bio. 20. 100669–100669. 3 indexed citations
6.
Adler, Julia, Roni Oren, & Yosef Shaul. (2023). Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy. Cancer Medicine. 12(9). 10781–10790. 2 indexed citations
7.
Oren, Roni, Jasmine Jacob‐Hirsch, Moshe Leitner, et al.. (2022). Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant. Frontiers in Oncology. 12. 959133–959133. 2 indexed citations
8.
Harpaz, Nofar, Noa Furth, Tomer‐Meir Salame, et al.. (2022). Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas. Molecular Cell. 82(14). 2696–2713.e9. 23 indexed citations
9.
Marrocco, Ilaria, Donatella Romaniello, Diana Drago-García, et al.. (2021). Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models. EMBO Molecular Medicine. 13(4). e13144–e13144. 18 indexed citations
10.
Romaniello, Donatella, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.. (2020). Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor. Cancers. 12(9). 2394–2394. 40 indexed citations
11.
Ben‐Hamo, Rotem, A. Berger, Nancy Gavert, et al.. (2020). Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nature Communications. 11(1). 3296–3296. 52 indexed citations
12.
Kalaora, Shelly, Joo Sang Lee, Eilon Barnea, et al.. (2020). Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma. Nature Communications. 11(1). 896–896. 106 indexed citations
13.
Cohen, Batya, Tal Raz, Roni Oren, et al.. (2020). BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression. Life Science Alliance. 3(4). e202000666–e202000666. 19 indexed citations
14.
Oren, Roni, Yoseph Addadi, Hila Gutman, et al.. (2018). Whole Organ Blood and Lymphatic Vessels Imaging (WOBLI). Scientific Reports. 8(1). 1412–1412. 22 indexed citations
15.
Radoul, Marina, Batya Cohen, Roni Oren, et al.. (2016). Genetic manipulation of iron biomineralization enhances MR relaxivity in a ferritin-M6A chimeric complex. Scientific Reports. 6(1). 26550–26550. 18 indexed citations
16.
Oren, Roni, et al.. (2013). Imaging aspects of the tumor stroma with therapeutic implications. Pharmacology & Therapeutics. 141(2). 192–208. 48 indexed citations
17.
Melkman-Zehavi, Tal, Roni Oren, Sharon Kredo‐Russo, et al.. (2011). miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors. The EMBO Journal. 30(5). 835–845. 230 indexed citations
18.
Oren, Roni, Itai Glinert, Vyacheslav Kalchenko, et al.. (2008). Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunology Immunotherapy. 58(1). 71–84. 83 indexed citations
19.
20.
Grodberg, Jennifer, et al.. (1990). Autonomous replication sequences in an extrachromosomal element of a pathogenicEntamoeba histolytica. Nucleic Acids Research. 18(18). 5515–5519. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuxiang Zhou Breakdown of academic impact, for papers by Chaoxin Hu Breakdown of academic impact, for papers by Pamela Hale Breakdown of academic impact, for papers by Seishi Nagamori Breakdown of academic impact, for papers by Junjeong Choi Breakdown of academic impact, for papers by Akimitsu Konishi Breakdown of academic impact, for papers by Yanping Gong Breakdown of academic impact, for papers by Chang Xian Li
Rankless by CCL
2026